Abrogation of cardiomyopathy in diabetic rats by escin – possible role of NF-κβ and MCP-1

References

• Addepalli, V., and Suryavanshi, S.V., 2018. Catechin attenuates diabetic autonomic neuropathy in streptozotocin induced diabetic rats. Biomedicine & Pharmacotherapy, 108, 1517–1523.
   PubMed Web of Science ®Google Scholar
• Avci, G., et al., 2010. Effects of escin mixture from the seeds of Aesculus hippocastanum on obesity in mice fed a high fat diet. Pharmaceutical Biology, 48 (3), 247–252.
   PubMed Web of Science ®Google Scholar
• Bhatt, L.K., and Veeranjaneyulu, A., 2012. A therapeutic approach to treat cardiovascular dysfunction of diabetes. Experimental and Toxicologic Pathology: official Journal of the Gesellschaft Fur Toxikologische Pathologie, 64 (7-8), 847–853.
   PubMedGoogle Scholar
• Boudina, S., and Abel, E.D., 2010. Diabetic cardiomyopathy, causes and effects. Reviews in Endocrine & Metabolic Disorders, 11 (1), 31–39.
   PubMed Web of Science ®Google Scholar
• Çiftçi, G.A., Işcan, A., and Kutlu, M., 2015. Escin reduces cell proliferation and induces apoptosis on glioma and lung adenocarcinoma cell lines. Cytotechnology, 67 (5), 893–904.
   PubMed Web of Science ®Google Scholar
• Dudek-Makuch, M., and Studzińska-Sroka, E., 2015. Horse chestnut – efficacy and safety in chronic venous insufficiency: an overview. Revista Brasileira de Farmacognosia, 25 (5), 533–541.
   Google Scholar
• Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics, 82 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• Fang, Z.Y., Prins, J.B., and Marwick, T.H., 2004. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocrine Reviews, 25 (4), 543–567.
   PubMed Web of Science ®Google Scholar
• Frangogiannis, N.G., et al., 2007. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation, 115 (5), 584–592.
   PubMed Web of Science ®Google Scholar
• Garud, M.S., and Kulkarni, Y.A., 2017a. Attenuation of renal damage in type I diabetic rats by umbelliferone – a coumarin derivative. Pharmacological Reports, 69 (6), 1263–1269.
   PubMed Web of Science ®Google Scholar
• Garud, M.S., and Kulkarni, Y.A., 2017b. Eugenol ameliorates renal damage in streptozotocin-induced diabetic rats. Flavour and Fragrance Journal, 32 (1), 54–62.
   Web of Science ®Google Scholar
• Garud, M.S., and Kulkarni, Y.A., 2018. Gallic acid attenuates type I diabetic nephropathy in rats. Chemico-Biological Interactions, 282, 69–76.
   PubMed Web of Science ®Google Scholar
• Gulsin, G.S., Athithan, L., and McCann, G.P., 2019. Diabetic cardiomyopathy: prevalence, determinants and potential treatments. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819834869.
   Web of Science ®Google Scholar
• IDF, 2019. IDF Diabetes Atlas, 9th edn. International Diabetes Federation. Brussels, Belgium.
   Google Scholar
• Jia, G., Hill, M.A., and Sowers, J.R., 2018. diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circulation Research, 122 (4), 624–638.
   PubMed Web of Science ®Google Scholar
• Kolwicz, S.C., and Tian, R., 2011. Glucose metabolism and cardiac hypertrophy. Cardiovascular Research, 90 (2), 194–201.
   PubMed Web of Science ®Google Scholar
• Liu, Q., Wang, S., and Cai, L., 2014. Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. Journal of Diabetes Investigation, 5 (6), 623–634.
   PubMed Web of Science ®Google Scholar
• Lorenzo, O., et al., 2011. Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators of Inflammation, 2011, 652097–652099.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., et al., 1951. Protein measurement with the folin. Journal of Biological Chemistry, 193 (1), 265–275.
   PubMed Web of Science ®Google Scholar
• Luck, H., 1965. Catalase. In: Methods of Enzymatic Analysis. New York and London: Academic Press, 885–894.
   Google Scholar
• Miki, T., et al., 2013. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Failure Reviews, 18 (2), 149–166.
   PubMed Web of Science ®Google Scholar
• Nazaruk, J., and Borzym-Kluczyk, M., 2015. The role of triterpenes in the management of diabetes mellitus and its complications. Phytochemistry Reviews : proceedings of the Phytochemical Society of Europe, 14 (4), 675–690.
   PubMed Web of Science ®Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95 (2), 351–358.
   PubMed Web of Science ®Google Scholar
• Oza, M., and Kulkarni, Y., 2020. Formononetin alleviates diabetic cardiomyopathy by inhibiting oxidative stress and upregulating SIRT1 in rats. Asian Pacific Journal of Tropical Biomedicine, 10 (6), 254.
   Web of Science ®Google Scholar
• Paoletti, F., Mocali, A., and Aldinucci, D., 1990. Superoxide-driven NAD(P)H oxidation induced by EDTA-manganese complex and mercaptoethanol. Chemico-Biological Interactions, 76 (1), 3–18.
   PubMed Web of Science ®Google Scholar
• Patlolla, J.M.R., and Rao, C.V., 2015. Anti-inflammatory and anti-cancer properties of β-Escin, a triterpene saponin. Current Pharmacology Reports, 1 (3), 170–178.
   Google Scholar
• Rimmon, A., et al., 2013. Escin chemosensitizes human pancreatic cancer cells and inhibits the nuclear factor-kappab signaling pathway. Biochemistry Research International, 2013, 251752–251759.
   PubMedGoogle Scholar
• Srijayanta, S., Raman, A., and Goodwin, B.L., 1999. A comparative study of the constituents of Aesculus hippocastanum and Aesculus indica. Journal of Medicinal Food, 2 (2), 45–50.
   PubMedGoogle Scholar
• Suryavanshi, S.V., and Kulkarni, Y.A., 2017. NF-κβ: a potential target in the management of vascular complications of diabetes. Frontiers in Pharmacology, 8 (NOV), 798–712.
   PubMedGoogle Scholar
• Suryavanshi, S.V., and Kulkarni, Y.A., 2020a. Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats. Life Sciences, 254, 117777.
   PubMed Web of Science ®Google Scholar
• Suryavanshi, S.V. and Kulkarni, Y.A., 2020b. Attenuation of cardiac autonomic neuropathy by escin in diabetic rats. Pharmacology, 106, 1–7.
   Web of Science ®Google Scholar